Roman M. Chicz

3.3k total citations · 2 hit papers
34 papers, 2.5k citations indexed

About

Roman M. Chicz is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Roman M. Chicz has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Roman M. Chicz's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Roman M. Chicz is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Roman M. Chicz collaborates with scholars based in United States, France and United Kingdom. Roman M. Chicz's co-authors include Robert G. Urban, Jack L. Strominger, Joan C. Gorga, Dario A.A. Vignali, W S Lane, William S. Lane, Lawrence J. Stern, Fred E. Regnier, J L Strominger and Massimo Trucco and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Roman M. Chicz

33 papers receiving 2.5k citations

Hit Papers

Specificity and promiscuity among naturally processed pep... 1992 2026 2003 2014 1993 1992 200 400 600

Peers

Roman M. Chicz
G. Larry Gartland United States
Steven M. Chamow United States
Carl‐Wilhelm Vogel United States
Nathan P. Croft Australia
I Hilgert Czechia
Lawrence D. Papsidero United States
Gillian Dekkers Netherlands
Peter Walden Germany
Nicola Ternette United Kingdom
G. Larry Gartland United States
Roman M. Chicz
Citations per year, relative to Roman M. Chicz Roman M. Chicz (= 1×) peers G. Larry Gartland

Countries citing papers authored by Roman M. Chicz

Since Specialization
Citations

This map shows the geographic impact of Roman M. Chicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman M. Chicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman M. Chicz more than expected).

Fields of papers citing papers by Roman M. Chicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman M. Chicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman M. Chicz. The network helps show where Roman M. Chicz may publish in the future.

Co-authorship network of co-authors of Roman M. Chicz

This figure shows the co-authorship network connecting the top 25 collaborators of Roman M. Chicz. A scholar is included among the top collaborators of Roman M. Chicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman M. Chicz. Roman M. Chicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Shaolong, et al.. (2024). Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2. Scientific Reports. 14(1). 2038–2038. 3 indexed citations
2.
Planas, Delphine, Lin Peng, Lingyi Zheng, et al.. (2024). Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants. Heliyon. 10(5). e27033–e27033.
3.
Berry, Catherine, Vincent Pavot, Natalie G. Anosova, et al.. (2023). Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters. SHILAP Revista de lepidopterología. 3(1). 75–75. 2 indexed citations
4.
Pavot, Vincent, Catherine Berry, Michael Kishko, et al.. (2023). Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates. Nature Communications. 14(1). 12 indexed citations
5.
Deng, Yixiang, Dansu Yuan, Taras M. Chicz, et al.. (2023). Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines. Cell Reports. 42(11). 113292–113292. 4 indexed citations
6.
Pavot, Vincent, Catherine Berry, Michael Kishko, et al.. (2022). Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates. Nature Communications. 13(1). 1699–1699. 25 indexed citations
8.
Wald, Anna, David M. Koelle, Kenneth H. Fife, et al.. (2011). Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons. Vaccine. 29(47). 8520–8529. 60 indexed citations
9.
Mo, Annie X., Cristina Musselli, Hong Chen, et al.. (2011). A heat shock protein based polyvalent vaccine targeting HSV-2: CD4+ and CD8+ cellular immunity and protective efficacy. Vaccine. 29(47). 8530–8541. 38 indexed citations
10.
Tomlinson, Andy J., Marina Hincapie, George E. Morris, & Roman M. Chicz. (2002). Global proteome analysis of a human gastric carcinoma. Electrophoresis. 23(18). 3233–3240. 20 indexed citations
11.
Peakman, Mark, Elizabeth Stevens, Tobias Lohmann, et al.. (1999). Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. Journal of Clinical Investigation. 104(10). 1449–1457. 115 indexed citations
12.
Chicz, Roman M., et al.. (1997). HLA-DP2: self peptide sequences and binding properties. The Journal of Immunology. 159(10). 4935–4942. 41 indexed citations
13.
Chicz, Roman M. & Robert G. Urban. (1994). Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development. Immunology Today. 15(4). 155–160. 27 indexed citations
14.
Urban, Robert G., Roman M. Chicz, & Jack L. Strominger. (1994). Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.. The Journal of Experimental Medicine. 180(2). 751–755. 43 indexed citations
15.
Urban, Robert G., Roman M. Chicz, W S Lane, et al.. (1994). A subset of HLA-B27 molecules contains peptides muchlonger than nonamers.. Proceedings of the National Academy of Sciences. 91(4). 1534–1538. 148 indexed citations
16.
Chicz, Roman M., et al.. (1994). Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. International Immunology. 6(11). 1639–1649. 70 indexed citations
17.
Chicz, Roman M., Robert G. Urban, Joan C. Gorga, et al.. (1993). Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.. The Journal of Experimental Medicine. 178(1). 27–47. 742 indexed citations breakdown →
18.
Vignali, Dario A.A., Robert G. Urban, Roman M. Chicz, & J L Strominger. (1993). Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. European Journal of Immunology. 23(7). 1602–1607. 68 indexed citations
19.
Chicz, Roman M. & Fred E. Regnier. (1990). Microenvironmental contributions to the chromatographic behavior of subtilisin in hydrophobic-interaction and reversed-phase chromatography. Journal of Chromatography A. 500. 503–518. 13 indexed citations
20.
Chicz, Roman M. & Fred E. Regnier. (1990). [32] High-performance liquid chromatography: Effective protein purification by various chromatographic modes. Methods in enzymology on CD-ROM/Methods in enzymology. 182. 392–421. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026